Top Markets
Coin of the day
Aarti Pharmalabs Limited Aarti Pharmalabs Limited

Aarti Pharmalabs Limited

AARTIPHARM
Classifica tra le azioni #10430
Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and... Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates; xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline; and acid and allied products, including sulphuric acid, sulphur trioxide, oil, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is headquartered in Mumbai, India.
Prezzo delle azioni
$9.28
Ultima sincronizzazione: 2026-08-28
Capitalizzazione di mercato
$841.31M
Variazione (1 giorno)
3.34%
Variazione (1 anno)
-2.77%
Paese
IN
Scambia Aarti Pharmalabs Limited (AARTIPHARM)

Categoria

Rapporto P/B per Aarti Pharmalabs Limited (AARTIPHARM)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Aarti Pharmalabs Limited, il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Aarti Pharmalabs Limited da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti